InvestorsHub Logo
Followers 11
Posts 385
Boards Moderated 0
Alias Born 08/12/2022

Re: None

Friday, 08/12/2022 9:44:54 PM

Friday, August 12, 2022 9:44:54 PM

Post# of 1456
10x-20x Potential in the cards DD

2 Buyouts of ROR1 Antibodies in the last year and half Merck 2.8 Billion &
Boehringer inks $1.5B NBE buyout. ROR1-directed antibody-drug .


ONCT 60 Million market cap Phase 3 starting with Abbie & deep diverse cutting edge pipeline. Tutes & Insiders own 40%+ of the 50 Million outstanding shares
79 million cash into 2024 lots of updates coming Q3 & $ Chart looks ripe for a massive reversal.


$ONCT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCT News